Equasens (EQS.PA) Stock Price
Equasens Price
Over the last 19 years Equasens grew revenue by 6.8% annually, reaching 236.52 M EUR. Earnings per share have grown at 9.2% per year over the last 19 years. For Equasens, the net margin of 16.6% is down versus 20.3% a few years ago. At today's price the dividend yield works out to roughly 4.36%. The payout ratio is around 49% of earnings. The dividend has grown at 9.6% per year over the past 19 years. The consensus 12-month price target for Equasens is 53.04 EUR, about 84.8% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.
Equasens stock price
Equasens business model & stock analysis
Frequently asked questions about Equasens
Pharmagest Interactive SA operates on a business model that combines both software publishing and IT services. As a leading provider in the healthcare sector, the company specializes in the development and integration of computerized management solutions for pharmacies, hospitals, and healthcare professionals. Pharmagest Interactive SA offers a wide range of innovative products and services, including pharmacy information systems, medication dispensing robots, patient monitoring tools, and digital solutions for telemedicine. By facilitating efficient and secure workflows, their solutions contribute to improving patient care and optimizing pharmaceutical processes. Pharmagest Interactive SA continues to innovate and adapt to the evolving needs of the healthcare industry, positioning itself as a reliable partner for digital transformation in the sector.
Pharmagest Interactive SA primarily operates in the healthcare industry.
The main competitors of Pharmagest Interactive SA in the market include leading healthcare technology companies such as Cerner Corporation, Allscripts Healthcare Solutions, and Epic Systems Corporation. These companies also provide innovative software solutions for healthcare management, electronic health records, and pharmacy point-of-sale systems. Pharmagest Interactive SA competes by offering comprehensive and customizable solutions specifically designed for pharmacies, hospitals, and healthcare institutions. With its unparalleled expertise and dedication, Pharmagest Interactive SA continues to stand out in the market, providing advanced technology solutions to enhance pharmacy operations and improve patient care.
Pharmagest Interactive SA is a leading company in the healthcare sector. Founded in 1980, the company has a rich history of providing innovative solutions and services to pharmacies and healthcare professionals. Pharmagest Interactive SA specializes in developing software for medication management, patient care, and pharmacy automation. With a strong commitment to leveraging technology in the healthcare industry, Pharmagest Interactive SA has grown to become a trusted partner for pharmacies across Europe. The company's dedication to delivering high-quality solutions has earned them a strong reputation and a competitive edge in the market. Pharmagest Interactive SA continues to evolve and adapt to the changing needs of the healthcare sector, ensuring enhanced patient outcomes and operational efficiency for its clients.
Pharmagest Interactive SA has achieved several significant milestones throughout its history. The company has successfully forged strategic partnerships with leading healthcare organizations, enhancing its market position and expanding its reach. Pharmagest has consistently demonstrated its commitment to innovation by developing cutting-edge technological solutions tailored for the healthcare sector. Furthermore, the company has achieved remarkable growth, both organically and through acquisitions, establishing itself as a key player in the pharmacy management software industry. Pharmagest's dedication to providing comprehensive and integrated services has been widely recognized, earning the company a strong reputation among investors and healthcare professionals alike.
Pharmagest Interactive SA is primarily present in France.
Pharmagest Interactive SA represents strong values and a dedicated corporate philosophy. The company is committed to excellence in the field of healthcare and technology solutions. Pharmagest Interactive SA places great importance on innovation, ensuring that they stay at the forefront of the industry. They prioritize customer satisfaction, aiming to provide exceptional products and services. With a focus on quality, reliability, and creating sustainable partnerships, Pharmagest Interactive SA aims to contribute to the advancement of healthcare worldwide. Their unwavering commitment to these values has made them a trusted name in the industry, thus solidifying their position as a leader in healthcare technology solutions.
Analysts currently set an average price target of 54.06 EUR for the Equasens stock (median: 53.04 EUR), implying +88.4 % versus the latest price. The consensus is based on 6 analyst ratings.
6 analysts currently rate the Equasens stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Equasens to generate revenue of 253.45 M EUR and earnings per share of 2.92 EUR.
The Equasens share (EQS.PA) is listed on 6 stock exchanges, including: London (0R9T.L), Frankfurt (PHF.F), München (PHF.MU), Paris (EQS.PA).
Pharmagest Interactive SA is a leading provider of IT solutions for the healthcare industry. The company is headquartered in France and operates in Europe, North America, and the Middle East. Pharmagest Interactive SA has five business areas that offer various IT solutions for pharmacies, hospitals, senior facilities, and retail. The pharmacy division offers specialized software solutions such as WinPharm and LGPI, which allow pharmacies to optimize their management and simplify their business processes. The solutions include inventory management, billing and accounting, and customer communication. Additionally, Pharmagest Interactive SA also offers an online pharmacy called easypharmacie, through which customers can order their medications online and have them delivered directly to their homes. In the hospital division, the company offers solutions for electronic medical records, patient management, mobile caregiving, and image analysis. These solutions allow hospitals to streamline their processes, increase efficiency, and improve patient satisfaction. The senior facility division offers IT solutions to enhance the management of nursing homes and senior residences. The solutions include resident management, staff and resource planning, as well as billing and accounting. These solutions can help senior facilities optimize their operations and increase the quality of care. In the retail division, Pharmagest Interactive SA offers solutions tailored specifically to retailers. The solutions include customer management, inventory management, point-of-sale systems, as well as marketing and analysis tools. With these solutions, retailers can increase sales, improve customer loyalty, and optimize their business processes. The telemedicine division offers a platform called "CareSpeak" that aims to improve communication between patients and healthcare facilities. With this solution, medical professionals can communicate quickly and effectively with patients without the need for physical contact. Pharmagest Interactive SA specializes in meeting the needs of the healthcare industry and offers IT solutions tailored to pharmacies, hospitals, senior facilities, retailers, and telemedicine providers. These comprehensive IT solutions help customers optimize their business processes, minimize risks, and improve the quality of healthcare.
The expected revenue of Equasens is 253.45 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Equasens is 44.69 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Equasens is currently 9.82. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Equasens stock.
The price-to-sales ratio (P/S) of Equasens is currently 1.73. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Equasens stock.
The Eulerpool Quality Score for Equasens is 6/10.
The ISIN of Equasens is FR0012882389. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Equasens is A14XZH. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Equasens is EQS.PA. The ticker symbol is used to trade Equasens shares on the stock exchange.
Equasens stock
Equasens Peer Group
Equasens Ticker
Equasens FIGI
All fundamentals and in-depth analysis of Equasens
Our stock analysis for Equasens stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Equasens. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.